New Approaches in Locoregional Therapies for Hepatocellular Carcinoma



Hepatocellular carcinoma (HCC) represent actually the fifth most common cancer worldwide, with liver transplantation and hepatic resection who represent the standard of care of curative treatment. Unfortunately, not all patient could benefit of curative treatment. For such patients, locoregional or systemic therapies represent a valid option in order to achieve the best survival possible.


A review of most interesting paper actually present in literature on locoregional treatment for nonresectable nontransplantable HCC was performed.


A detailed description on each different approach has been detailed in each chapter.


In case of nontransplantable and nonresectable HCC, locoregional treatment represent a valid alternative in management of this patients.